RENAL CELL ACCRU-GU-1703

Study #ACCRU-GU-1703

Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First Line or Post-immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC).

Back To Clinical Trials